Literature DB >> 17324406

Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestine.

Seung G Kang1, Ronald J Piniecki, Harm Hogenesch, Hyung W Lim, Eric Wiebke, Stephen E Braun, Satoshi Matsumoto, Chang H Kim.   

Abstract

BACKGROUND AND AIMS: It has been unclear which chemokine network is involved in migration of T-cell subsets to chronically inflamed lesions of the intestine. SAMP1/YP mice develop a spontaneous chronic transmural intestinal lesion specifically in the ileum. Using these mice, we investigated the gut chemokine network involved in specific migration of T-cell subsets to the inflamed lesion of the intestine.
METHODS: We performed expression analyses of chemokines and their receptors, chemokine receptor blocking studies, and migration studies in vitro and in vivo to identify the gut chemokine network induced in intestinal inflammation and to determine its role in migration of conventional and FoxP3(+) suppressor T cells to the inflamed intestine.
RESULTS: The expression of homeostatic chemokines was largely unchanged in the inflamed lesion of SAMP1/YP mice compared with control mice. However, an additional chemokine axis (CCL5-CCR5) was up-regulated in the inflamed intestine of SAMP1/YP mice compared with control mice. Activated T cells of SAMP1/YP mice compared with control mice were hyperresponsive to CCL5 in chemotaxis. CCR5(+) T cells preferentially migrated to the inflamed lesion, which can be blocked by a CCR5 antagonist. Importantly, the FoxP3(+) regulatory T cells of the inflamed lesion of SAMP1/YP mice highly expressed CCR5. CCR5 blockade suppressed the migration of FoxP3(+) T cells into the inflamed intestine and significantly exacerbated the intestinal inflammation.
CONCLUSIONS: The CCL5-CCR5 chemokine axis is involved in preferential recruitment of FoxP3(+) regulatory T cells, which prevents further exacerbation of chronic inflammation in the intestine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17324406     DOI: 10.1053/j.gastro.2007.01.008

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  28 in total

Review 1.  Immunopathogenesis of IBD: current state of the art.

Authors:  Heitor S P de Souza; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-12-02       Impact factor: 46.802

2.  High and low vitamin A therapies induce distinct FoxP3+ T-cell subsets and effectively control intestinal inflammation.

Authors:  Seung G Kang; Chuanwu Wang; Satoshi Matsumoto; Chang H Kim
Journal:  Gastroenterology       Date:  2009-07-24       Impact factor: 22.682

Review 3.  Heterogeneity and Stability in Foxp3+ Regulatory T Cells.

Authors:  Booki Min
Journal:  J Interferon Cytokine Res       Date:  2017-07-11       Impact factor: 2.607

4.  CCL5-403, CCR5-59029, and Delta32 polymorphisms and cancer risk: a meta-analysis based on 20,625 subjects.

Authors:  Houqun Ying; Jie Wang; Xueren Gao
Journal:  Tumour Biol       Date:  2014-04-01

5.  Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stability.

Authors:  Jee H Lee; John P Lydon; Chang H Kim
Journal:  Eur J Immunol       Date:  2012-08-06       Impact factor: 5.532

Review 6.  Role of regulatory T cell in the pathogenesis of inflammatory bowel disease.

Authors:  Akiko Yamada; Rieko Arakaki; Masako Saito; Takaaki Tsunematsu; Yasusei Kudo; Naozumi Ishimaru
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

7.  GATA3 controls Foxp3⁺ regulatory T cell fate during inflammation in mice.

Authors:  Elizabeth A Wohlfert; John R Grainger; Nicolas Bouladoux; Joanne E Konkel; Guillaume Oldenhove; Carolina Hager Ribeiro; Jason A Hall; Ryoji Yagi; Shruti Naik; Ravikiran Bhairavabhotla; William E Paul; Remy Bosselut; Gang Wei; Keji Zhao; Mohamed Oukka; Jinfang Zhu; Yasmine Belkaid
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

Review 8.  Phenotypical and functional specialization of FOXP3+ regulatory T cells.

Authors:  Daniel J Campbell; Meghan A Koch
Journal:  Nat Rev Immunol       Date:  2011-02       Impact factor: 53.106

9.  CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells.

Authors:  Marcin Dobaczewski; Ying Xia; Marcin Bujak; Carlos Gonzalez-Quesada; Nikolaos G Frangogiannis
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

10.  Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection.

Authors:  J Christian J Ray; JoAnne L Flynn; Denise E Kirschner
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.